Clinical Trial Update: PSMA Specific [68Ga]-P137 Peptide Probe for PET Imaging in Prostate Cancer [NA]

View source ↗

Summary

Clinical trial update for a PSMA-specific [68Ga]-P137 peptide probe used for PET imaging in prostate cancer; the trial status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• PSMA-specific [68Ga]-P137 peptide probe (68Ga-labeled P137 peptide PET imaging agent)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Prostate Cancer | NA | Status: ACTIVE_NOT_RECRUITING